117 related articles for article (PubMed ID: 1533049)
1. Adoptive immunotherapy with bispecific antibodies: targeting through macrophages.
Chokri M; Girard A; Borrelly MC; Oleron C; Romet-Lemonne JL; Bartholeyns J
Res Immunol; 1992 Jan; 143(1):95-9. PubMed ID: 1533049
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the ability of red cells sensitized with a bispecific anti-D x anti-Fc gamma RIII Fab fragment to activate human K cells and peritoneal macrophages through Fc gamma RIII.
Bakács T; Hadley AG; Kumpel BM; Segal DM; Banhidy F
Immunol Lett; 1994 Sep; 42(1-2):91-5. PubMed ID: 7829136
[TBL] [Abstract][Full Text] [Related]
3. Fc receptors for IgG (Fc gamma Rs) on human monocytes and macrophages are not infectivity receptors for human immunodeficiency virus type 1 (HIV-1): studies using bispecific antibodies to target HIV-1 to various myeloid cell surface molecules, including the Fc gamma R.
Connor RI; Dinces NB; Howell AL; Romet-Lemonne JL; Pasquali JL; Fanger MW
Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9593-7. PubMed ID: 1835086
[TBL] [Abstract][Full Text] [Related]
4. Production of macrophage-activated killer cells for targeting of glioblastoma cells with bispecific antibody to FcgammaRI and the epidermal growth factor receptor.
Wallace PK; Romet-Lemonne JL; Chokri M; Kasper LH; Fanger MW; Fadul CE
Cancer Immunol Immunother; 2000 Nov; 49(9):493-503. PubMed ID: 11092616
[TBL] [Abstract][Full Text] [Related]
5. Bispecific anti-human red blood Rhesus-D antigen x anti Fc gamma RI targeted antibody-dependent cell-mediated cytotoxicity and phagocytosis by mononuclear leucocytes.
Deramoudt EX; Gilard C; Lepine N; Alonso JM; Romet-Lemonne JL
Clin Exp Immunol; 1992 Aug; 89(2):310-4. PubMed ID: 1386300
[TBL] [Abstract][Full Text] [Related]
6. Phase I trial of intravenous infusion of ex-vivo-activated autologous blood-derived macrophages in patients with non-small-cell lung cancer: toxicity and immunomodulatory effects.
Faradji A; Bohbot A; Schmitt-Goguel M; Roeslin N; Dumont S; Wiesel ML; Lallot C; Eber M; Bartholeyns J; Poindron P
Cancer Immunol Immunother; 1991; 33(5):319-26. PubMed ID: 1651160
[TBL] [Abstract][Full Text] [Related]
7. Lysis of murine B lymphoma cells by transgenic phagocytes via a human Fc gamma RI x murine MHC class II bispecific antibody.
Heijnen IA; Glennie MJ; van de Winkel JG
Cancer Immunol Immunother; 1997; 45(3-4):166-70. PubMed ID: 9435865
[TBL] [Abstract][Full Text] [Related]
8. Initial trial of bispecific antibody-mediated immunotherapy of CD15-bearing tumors: cytotoxicity of human tumor cells using a bispecific antibody comprised of anti-CD15 (MoAb PM81) and anti-CD64/Fc gamma RI (MoAb 32).
Ball ED; Guyre PM; Mills L; Fisher J; Dinces NB; Fanger MW
J Hematother; 1992; 1(1):85-94. PubMed ID: 1365020
[TBL] [Abstract][Full Text] [Related]
9. Antibody-dependent enhancement of dengue virus infection mediated by bispecific antibodies against cell surface molecules other than Fc gamma receptors.
Mady BJ; Erbe DV; Kurane I; Fanger MW; Ennis FA
J Immunol; 1991 Nov; 147(9):3139-44. PubMed ID: 1680925
[TBL] [Abstract][Full Text] [Related]
10. Comparative efficiencies of bispecific F(ab'gamma)2 and chimeric mouse/human IgG antibodies in recruiting cellular effectors for cytotoxicity via Fc gamma receptors.
Greenman J; Hogg N; Nikoletti S; Slade C; Stevenson G; Glennie M
Cancer Immunol Immunother; 1992; 34(6):361-9. PubMed ID: 1532922
[TBL] [Abstract][Full Text] [Related]
11. Differential effect of cytokine treatment on Fc alpha receptor I- and Fc gamma receptor I-mediated tumor cytotoxicity by monocyte-derived macrophages.
Keler T; Wallace PK; Vitale LA; Russoniello C; Sundarapandiyan K; Graziano RF; Deo YM
J Immunol; 2000 Jun; 164(11):5746-52. PubMed ID: 10820252
[TBL] [Abstract][Full Text] [Related]
12. Bispecific antibodies targeting cancer cells.
Peipp M; Valerius T
Biochem Soc Trans; 2002 Aug; 30(4):507-11. PubMed ID: 12196124
[TBL] [Abstract][Full Text] [Related]
13. Adoptive immunotherapy of solid tumors with activated macrophages: experimental and clinical results.
Bartholeyns J; Lopez M; Andreesen R
Anticancer Res; 1991; 11(3):1201-4. PubMed ID: 1888150
[TBL] [Abstract][Full Text] [Related]
14. A human Fc gamma RI/CD64 transgenic model for in vivo analysis of (bispecific) antibody therapeutics.
Heijnen IA; Van de Winkel JG
J Hematother; 1995 Oct; 4(5):351-6. PubMed ID: 8581368
[TBL] [Abstract][Full Text] [Related]
15. Effect of recombinant IFN-gamma (rIFN-gamma) on the mechanism of human macrophage IgG FcRI-mediated cytotoxicity. rIFN-gamma decreases inhibition by cytophilic human IgG and changes the cytolytic mechanism.
Van Schie RC; Verstraten RG; Van de Winkel JG; Tax WJ; de Mulder PH
J Immunol; 1992 Jan; 148(1):169-76. PubMed ID: 1530794
[TBL] [Abstract][Full Text] [Related]
16. Interferon gamma enhances lymphokine-activated killer cell adhesion but not lysis of head and neck squamous cell carcinoma.
Scher RL; Carras A; Schwab D; Richtsmeier WJ; Koch WM
Arch Otolaryngol Head Neck Surg; 1995 Nov; 121(11):1271-5. PubMed ID: 7576474
[TBL] [Abstract][Full Text] [Related]
17. Potentiation of tumor lysis by a bispecific antibody that binds to CA19-9 antigen and the Fc gamma receptor expressed by human large granular lymphocytes.
de Palazzo IG; Gercel-Taylor C; Kitson J; Weiner LM
Cancer Res; 1990 Nov; 50(22):7123-8. PubMed ID: 2146012
[TBL] [Abstract][Full Text] [Related]
18. Preclinical studies combining bispecific antibodies with cytokine-stimulated effector cells for immunotherapy of renal cell carcinoma.
Elsässer D; Stadick H; Stark S; Van de Winkel JG; Gramatzki M; Schrott KM; Valerius T; Schafhauser W
Anticancer Res; 1999; 19(2C):1525-8. PubMed ID: 10365137
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a new monoclonal anti-Fc gamma RII antibody, AT10, and its incorporation into a bispecific F(ab')2 derivative for recruitment of cytotoxic effectors.
Greenman J; Tutt AL; George AJ; Pulford KA; Stevenson GT; Glennie MJ
Mol Immunol; 1991 Nov; 28(11):1243-54. PubMed ID: 1835758
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the antibody-dependent cytotoxic capabilities of individual human monocytes. Role of Fc gamma RI and Fc gamma RII and the effects of cytokines at the single cell level.
Connor RI; Shen L; Fanger MW
J Immunol; 1990 Sep; 145(5):1483-9. PubMed ID: 1696598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]